ArticleClinical interventions in aging2026
Development and Validation of a Predictive Model for Mild Cognitive Impairment in Older Adults with Multimorbidity.
Article in Clinical interventions in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify factors associated with mild cognitive impairment (MCI) in older adults with multimorbidity and to develop and validate a predictive model for early screening. Methods: This cross-sectional study consecutively enrolled 238 older adult inpatients with multimorbidity at the Affiliated Kangning Hospital of Wenzhou Medical University, China, between April 2022 and February 2025. Participants were assessed using a self-designed general information questionnaire and the Montreal Cognitive Assessment Basic Scale (MoCA-B). MCI was diagnosed according to the Chinese Expert Consensus. Associated factors were identified using logistic regression analysis. A nomogram prediction model was constructed based on these factors. The model's performance was evaluated using the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA). An external validation cohort (n=68) was used to further test the model. Results: MCI prevalence was 26.81%. Risk factors: age ≥80 years (OR=3.23), hearing impairment (OR=4.04), and emotional disorders (OR=3.25). Protective factors: higher education (OR=0.23), more frequent physical exercise (OR=0.15), and more frequent social activities (OR=0.26) (all P<0.05). The AUC was 0.862 (training) and 0.832 (external validation). Calibration curves showed good agreement, and DCA indicated net clinical benefit across threshold probabilities of (10-65%). Conclusion: Age, hearing impairment, emotional disorders, education, physical exercise, and social activities are significantly associated with MCI in older adults with multimorbidity. The nomogram demonstrates good predictive accuracy and clinical utility, aiding early identification and targeted prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.